Pascale Witz, president and CEO, GE Healthcare, Medical Diagnostics
March 19, 2009- John Dineen, president and CEO of GE Healthcare, has appointed Pascale Witz to the position of president and CEO, GE Healthcare, Medical Diagnostics. In her most recent assignment,
Ms. Witz led GE Healthcare’s Healthcare Systems Interventional global business, which researches and develops innovative medical technologies to help physicians diagnose and treat disease earlier, faster and more accurately.
“Leading the GE Medical Diagnostics team is an honor,” said Witz. “I’m eager to continue the mission of advancing medicine through novel diagnostic agents. We will raise the bar in diagnosing critical diseases such as Parkinson’s disease, Alzheimer’s and heart failure.”
“Pascale has a breadth of experience that makes her an ideal person to lead the Medical Diagnostics business,” said Dineen. “She brings an extensive background in molecular biology as well as imaging, both of which are critical to driving Medical Diagnostics’ development of its portfolio of innovative molecular diagnostic imaging agents.”
For more information: www.gehealthcare.com
April 01, 2026 
